• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tiziana Life Sciences Ltd (NQ: TLSA )

    0.9001 +0.0021 (+0.23%)
    Streaming Delayed Price Updated: 12:56 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Tiziana Life Sciences Ltd

    < Previous 1 2 3 4 5 Next >
    Tesla Surges To 15-Month High On Election; Musk-Trump Alliance In Focus
    Tesla stock is set to hit a 15-month high. 
    Via Investor's Business Daily
    Cathie Wood Sells Tesla Before Election; Musk Cabinet Position "Not What Shareholders Want To See"
    Tesla stock flashed a sell signal Monday and is well below a traditional buy point. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building
    Consumer support for robotaxis is low for people who have not been inside a self-driving vehicle or live in a city where the vehicles operate. 
    Via Benzinga
    The 3 Best EV Stocks to Buy in August 2024
    The best EV stocks may face an uphill battle, but their share prices seem too depressed after the latest plunge. 
    Via InvestorPlace
    Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
    Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding 
    Via News Direct
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    EXCLUSIVE: Top Tesla Options Trades Recommended By Trading Expert
    Trading expert Anne-Marie Baiynd shared option trade ideas for Tesla on Benzinga's YouTube, discussing potential positive catalysts and bullish strategies. 
    Via Benzinga
    Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    7 Battered Blue-Chip Stocks to Bounce From Your Portfolio This Spring
    Not all big companies are doing well in the stock market. For various reasons, these battered blue-chip stocks are struggling mightily. 
    Via InvestorPlace
    Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    3 EV Stocks to Buy on the Dip: March 2024
    The electric vehicle market slump has significantly impacted many EV stocks to buy - But the slump will not last forever. 
    Via InvestorPlace
    Topics Electric Vehicles
    Exposures Electric Vehicles
    3 EV Stocks to Buy for the Next Bull Run: March 2024
    EV stocks have broadly underperformed the market in 2024, which has, in turn, created a number of opportunities to buy at a bargain. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    7 Over-Hyped Stocks to Sell Before They Plunge
    It wasn't too long ago that these stocks were considered hot commodities. But now they're just overhyped stocks to sell. 
    Via InvestorPlace
    Tesla Shares Hardly Damaged Despite Recall: Full Self-Driving Is Elon Musk's 'Holy Grail,' Analyst Says
    Tesla shares fell only slightly. And auto recalls are nothing new. Recall how, in 1981, Ford issued a recall on 21 million vehicles. 
    Via Benzinga
    Topics Product Recall
    Exposures Legal Product Safety
    Don't Get Caught In Equity Rally Hype: Lessons From 2023 To Remember In 2024
    After a volatile 2023, equity markets appear to be rallying into 2024. Can they keep it up? 
    Via Benzinga
    Tiziana Expects To Start Enrolling Patients in Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using its Novel Intranasal Monoclonal Antibody Foralumab
    --News Direct-- 
    Via News Direct
    Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab
    This month, Tiziana Life Sciences (NASDAQ: TLSA) expects to start enrolling patients for a phase 2a trial of Foralumab, an immunomodulation therapy for Secondary Progressive Multiple Sclerosis (SPMS)... 
    Via Benzinga
    SPDR ETF Report For Tuesday, November 21
    Via Talk Markets
    Topics ETFs
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Pre-market stock movers are a hot topic worth checking out on Wednesday and we have all the latest news happening this morning! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Tiziana Life Sciences reveals "exciting" clinical data from latest MS trial
    --News Direct-- 
    Via News Direct
    Tiziana Life Sciences reports six-month PET scan results for MS patients
    --News Direct-- 
    Via News Direct
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.